- Home
- CLDI vs AUST Comparison
CLDI vs AUST Comparison
Compare CLDI & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- AUST
- Stock Information
- Founded
- CLDI 2014
- AUST 2020
- Country
- CLDI United States
- AUST Canada
- Employees
- CLDI N/A
- AUST N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- AUST
- Sector
- CLDI Health Care
- AUST
- Exchange
- CLDI Nasdaq
- AUST Nasdaq
- Market Cap
- CLDI 20.2M
- AUST 21.1M
- IPO Year
- CLDI N/A
- AUST 2022
- Fundamental
- Price
- CLDI $1.62
- AUST $1.73
- Analyst Decision
- CLDI
- AUST
- Analyst Count
- CLDI 0
- AUST 0
- Target Price
- CLDI N/A
- AUST N/A
- AVG Volume (30 Days)
- CLDI 485.8K
- AUST 129.7K
- Earning Date
- CLDI 11-11-2025
- AUST 11-05-2025
- Dividend Yield
- CLDI N/A
- AUST N/A
- EPS Growth
- CLDI N/A
- AUST N/A
- EPS
- CLDI N/A
- AUST N/A
- Revenue
- CLDI N/A
- AUST N/A
- Revenue This Year
- CLDI N/A
- AUST N/A
- Revenue Next Year
- CLDI N/A
- AUST N/A
- P/E Ratio
- CLDI N/A
- AUST N/A
- Revenue Growth
- CLDI N/A
- AUST N/A
- 52 Week Low
- CLDI $1.51
- AUST $0.87
- 52 Week High
- CLDI $46.68
- AUST $3.19
- Technical
- Relative Strength Index (RSI)
- CLDI 30.80
- AUST 61.44
- Support Level
- CLDI $1.51
- AUST $1.78
- Resistance Level
- CLDI $1.68
- AUST $1.95
- Average True Range (ATR)
- CLDI 0.12
- AUST 0.13
- MACD
- CLDI 0.13
- AUST 0.01
- Stochastic Oscillator
- CLDI 28.38
- AUST 65.18
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).